Cargando…

Salvage image guided radiation therapy to the prostate after cryotherapy failure

PURPOSE: Cryotherapy is an option for the primary treatment of localized prostate cancer, along with radical prostatectomy, external beam radiation therapy, and brachytherapy. Although it is known that local recurrence can occur in >20% of patients treated with primary cryotherapy, unfortunately...

Descripción completa

Detalles Bibliográficos
Autores principales: Hopper, Austin B., Sandhu, Ajay P.S., Parsons, J. Kellogg, Rose, Brent, Einck, John P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856984/
https://www.ncbi.nlm.nih.gov/pubmed/29556580
http://dx.doi.org/10.1016/j.adro.2017.09.001
_version_ 1783307385400459264
author Hopper, Austin B.
Sandhu, Ajay P.S.
Parsons, J. Kellogg
Rose, Brent
Einck, John P.
author_facet Hopper, Austin B.
Sandhu, Ajay P.S.
Parsons, J. Kellogg
Rose, Brent
Einck, John P.
author_sort Hopper, Austin B.
collection PubMed
description PURPOSE: Cryotherapy is an option for the primary treatment of localized prostate cancer, along with radical prostatectomy, external beam radiation therapy, and brachytherapy. Although it is known that local recurrence can occur in >20% of patients treated with primary cryotherapy, unfortunately there is a paucity of data on later salvage treatments. The use of external beam radiation therapy is an attractive option after cryotherapy failure, but there is little data on its efficacy and toxicity. We evaluated the biochemical control and complication rates of salvage dose-escalated image guided intensity modulated radiation therapy (IG-IMRT) after cryotherapy failure. METHODS AND MATERIALS: Patients who were treated at our institution from 2005 to 2016 were reviewed for those who underwent cryotherapy as initial treatment followed by salvage IGRT. Patients were treated with dose-escalated IG-IMRT using standard treatment margins of 3 mm posterior and 7 mm in all other directions and daily cone beam computed tomography or kv imaging to implanted fiducial markers. Biochemical progression was defined in accordance with the Phoenix consensus conference definition. RESULTS: Eight patients were identified as having received post-cryotherapy salvage radiation within the study period. The median total dose was 77.7 Gy (range, 75.6-81.0 Gy). Median follow-up was 55 months (range, 6-88 months). Six patients remained biochemically controlled at the latest follow-up. One patient developed distant metastases after 22 months and one experienced biochemical failure at 30 months with no evidence of distant metastases. No patients experienced acute gastrointestinal toxicities of grade 2 or higher. There were no cases of late gastrointestinal or genitourinary toxicity. CONCLUSIONS: High-dose IG-IMRT results in high rates of salvage and extremely low rates of serious late toxicity for patients with locally recurrent prostate cancer after cryotherapy. Although the results are encouraging, given the small number of patients in this and other series, we remain cautious with regard to this treatment and believe the use of salvage radiation therapy after cryotherapy warrants further study.
format Online
Article
Text
id pubmed-5856984
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-58569842018-03-19 Salvage image guided radiation therapy to the prostate after cryotherapy failure Hopper, Austin B. Sandhu, Ajay P.S. Parsons, J. Kellogg Rose, Brent Einck, John P. Adv Radiat Oncol Genitourinary Cancer PURPOSE: Cryotherapy is an option for the primary treatment of localized prostate cancer, along with radical prostatectomy, external beam radiation therapy, and brachytherapy. Although it is known that local recurrence can occur in >20% of patients treated with primary cryotherapy, unfortunately there is a paucity of data on later salvage treatments. The use of external beam radiation therapy is an attractive option after cryotherapy failure, but there is little data on its efficacy and toxicity. We evaluated the biochemical control and complication rates of salvage dose-escalated image guided intensity modulated radiation therapy (IG-IMRT) after cryotherapy failure. METHODS AND MATERIALS: Patients who were treated at our institution from 2005 to 2016 were reviewed for those who underwent cryotherapy as initial treatment followed by salvage IGRT. Patients were treated with dose-escalated IG-IMRT using standard treatment margins of 3 mm posterior and 7 mm in all other directions and daily cone beam computed tomography or kv imaging to implanted fiducial markers. Biochemical progression was defined in accordance with the Phoenix consensus conference definition. RESULTS: Eight patients were identified as having received post-cryotherapy salvage radiation within the study period. The median total dose was 77.7 Gy (range, 75.6-81.0 Gy). Median follow-up was 55 months (range, 6-88 months). Six patients remained biochemically controlled at the latest follow-up. One patient developed distant metastases after 22 months and one experienced biochemical failure at 30 months with no evidence of distant metastases. No patients experienced acute gastrointestinal toxicities of grade 2 or higher. There were no cases of late gastrointestinal or genitourinary toxicity. CONCLUSIONS: High-dose IG-IMRT results in high rates of salvage and extremely low rates of serious late toxicity for patients with locally recurrent prostate cancer after cryotherapy. Although the results are encouraging, given the small number of patients in this and other series, we remain cautious with regard to this treatment and believe the use of salvage radiation therapy after cryotherapy warrants further study. Elsevier 2017-09-27 /pmc/articles/PMC5856984/ /pubmed/29556580 http://dx.doi.org/10.1016/j.adro.2017.09.001 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Genitourinary Cancer
Hopper, Austin B.
Sandhu, Ajay P.S.
Parsons, J. Kellogg
Rose, Brent
Einck, John P.
Salvage image guided radiation therapy to the prostate after cryotherapy failure
title Salvage image guided radiation therapy to the prostate after cryotherapy failure
title_full Salvage image guided radiation therapy to the prostate after cryotherapy failure
title_fullStr Salvage image guided radiation therapy to the prostate after cryotherapy failure
title_full_unstemmed Salvage image guided radiation therapy to the prostate after cryotherapy failure
title_short Salvage image guided radiation therapy to the prostate after cryotherapy failure
title_sort salvage image guided radiation therapy to the prostate after cryotherapy failure
topic Genitourinary Cancer
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856984/
https://www.ncbi.nlm.nih.gov/pubmed/29556580
http://dx.doi.org/10.1016/j.adro.2017.09.001
work_keys_str_mv AT hopperaustinb salvageimageguidedradiationtherapytotheprostateaftercryotherapyfailure
AT sandhuajayps salvageimageguidedradiationtherapytotheprostateaftercryotherapyfailure
AT parsonsjkellogg salvageimageguidedradiationtherapytotheprostateaftercryotherapyfailure
AT rosebrent salvageimageguidedradiationtherapytotheprostateaftercryotherapyfailure
AT einckjohnp salvageimageguidedradiationtherapytotheprostateaftercryotherapyfailure